The Medicines Company Receives Complete Response Letter From FDA Requesting Additional Information for New Drug Application for Its Antiplatelet Agent Cangrelor

[Marketwired] – The Medicines Company today announced that the U.S. Food and Drug Administration has issued a Complete Response Letter for the Company’s new drug application for its investigational intravenous antiplatelet … more

View todays social media effects on MDCO

View the latest stocks trending across Twitter. Click to view dashboard

See who The is hiring next, click here to view